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RESILIENT Criteria Patients
Patrick A. Stone. West Virginia University, Charleston, WV
Objectives: The self-expanding nitinol stent, LifeStent (Bard Periph-
eral Vascular, Tempe, Ariz), is commonly used in endovascular interven-
tions for superﬁcial femoral and popliteal arterial stenosis. Food and
Drug Administration approval of the device was based on the RESIL-
IENT trial, which demonstrated LifeStent utilization having superior
angiographic results and patency rates at 12 months compared with angio-
plasty alone. Patient inclusion criteria in the RESILIENT trial were highly
stringent and excluded patients with critical limb ischemia. The purpose of
our study was to determine outcomes of patients receiving the LifeStent
for peripheral arterial disease including individuals with severe disease
progression.
Methods: All patients receiving a LifeStent during femoropopliteal
endovascular interventions between June 2006 and May 2012 with
duplex-ultrasound/angiographic follow-up or limb amputation were
reviewed. Patients with acute limb ischemia or previous revascularization
in the limb of interest were excluded. Patient demographics, Rutherford
classiﬁcation and anatomic factors (TransAtlantic Inter-Society Consensus
[TASC] II classiﬁcation, lesion length, and runoff vessel status) were deter-
mined. Outcomes evaluated included limb patency and freedom from limb
loss. Loss of primary patency deﬁned as vessel occlusion or needed for target
vessel revascularization.
Results: A total of 321 procedures in 272 patients employed the
LifeStent during the study time period, with 252 procedures having
duplex-ultrasound/angiographic follow-up. Eight-six procedures were
excluded from analysis due to limbs having acute limb ischemia or
a prior stent or bypass graft, leaving for analysis 166 limbs in 151
patients having the LifeStent utilized in de novo vessels (54% male;
mean age, 68 6 12 years). Eighty percent did not meet RESILIENT
criteria. Exclusion included a Rutherford category greater than 3
(51%), TASC II classiﬁcations C/D (51%), zero runoff vessels to the
foot (6%) or stent placement outside the zone deﬁned (18%). Median
follow-up period for patency was 8 months (range, 6 days to 37
months). Primary patency rates for all limbs were 81% at 6 months
and 50% at 12 months. TASC II classiﬁcation did not signiﬁcantly
affect rates of primary patency (P ¼ .30) or primary-assisted patency
(P ¼ .43). Predictors for loss of primary patency included vessel occlu-
sion (P ¼ .01) and the absence of clopidogrel at discharge (P ¼ .001).
Fifteen limbs were amputated with freedom from limb loss at 12
months being 92%. A preintervention Rutherford category greater
than 3 predicted limb lost (P ¼ .01).
Conclusions: The LifeStent is a viable option for patients with periph-
eral arterial disease regardless of disease severity.
Most Complications of Common Femoral Endarterectomy Occur after
Hospital Discharge
Bao-Ngoc H. Nguyen, Richard Neville, Mustafa Abugideiri, Rodeen
Rahbar, Richard Aur, Anton Sidawy. George Washington University, D.C.
Objectives: Common femoral endarterectomy for limited arterial
occlusive disease is performed commonly because it is considered a short
and fairly low-risk procedure. This study investigates the timing of 30-day
outcomes of this procedure.
Methods: All patients who underwent common femoral endarterec-
tomy in the National Surgical Quality Improvement Program database
between 2005 and 2010 were selected. After the procedure’s mortality
and morbidities were identiﬁed, we speciﬁcally focused on the timing of
event occurrences before and after hospital discharge.
Results: There were a total of 1843 common femoral endarterecto-
mies performed during that period. The average operative time was 146 6
69.5 minutes, and 10% of patients needed to return to the operating
room. The average length of stay was 4 6 5.8 days; 90% of patients
were discharged within 1 week of surgery. Although cardiovascular events,
renal dysfunction, and pulmonary complication rates were relatively low
(Table), there was a 3.4% mortality rate, almost one-half of which
occurred after the ﬁrst week. Wound infection rate was 3%; 94% of which
occurred after the ﬁrst week. Overall, there was a 10% rate of combined
mortality/morbidity, and more than 60% of these events occurred after
the ﬁrst week.
Conclusions: Although common femoral endarterectomy is consid-
ered a relatively benign procedure, it still has signiﬁcant complication rate.
However, a signiﬁcant percentage of these complications occurred after
patients are discharged from the hospital. Close postoperative follow-up
should be considered.Table. Thirty-day outcomes and timing of event occurrence after
common femoral endarterectomy
Weeks after surgeryn ¼ 1843
Events
n (%) 1 2 3 $4Mortality 62 (3.4%) 31 (53.5%) 12 (20.7%) 4 (6.9%) 11 (19.0%)
Graft failure 21 (1.1%) 8 (38.1%) 7 (33.3%) 3 (14.3%) 3 (14.3%)
Cardio 27 (1.5%) 19 (70.4%) 4 (14.8%) 1 (3.7%) 3 (11.1%)
Clot 25 (1.4%) 8 (32.0%) 6 (24.0%) 8 (32.0%) 3 (12.0%)
Renal 16 (0.9%) 10 (62.5%) 4 (25.0%) 2 (12.5%) 0 (0%)
Pneumo 61 (3.3%) 38 (63.3%) 11 (18.3%) 8 (13.3%) 3 (5.0%)
Wound 49 (2.7%) 3 (6.1%) 20 (40.8%) 14 (28.6%) 12 (24.5%)
Sepsis 47 (2.6%) 12 (26.7%) 19 (42.2%) 7 (15.6%) 7 (15.6%)
Composite 191 (10.4%) 68 (36.2%) 51 (27.1%) 37 (19.7%) 32 (17.0%)Rapid Fire Presentations
Branched Surgical Grafts for Aortic Reconstruction in Connective
Tissue Disorder Patients: The Emerging Standard for Repair
Dean J. Arnaoutakis, Brandon W. Propper, Natalia O. Glebova, Ying Wei
Lum, Christopher J. Abularrage, James H. Black III. The Johns Hopkins
Hospital, Baltimore, Md
Objectives: Connective tissue disorders (CTD) can predispose
patients to aneurysmal dilation of the entire aorta. Carrel patch or inclusion
patches have been a long standing method for branch reconstruction but
leaves aortic tissue at risk for recurrent aneurysm after repair. Furthermore,
re-do aortic procedures carry substantially higher procedural risk than index
operations and, thus, should be avoided. The purpose of this study is to
evaluate the performance of branched surgical grafts for aortic reconstruc-
tion in thoracoabdominal aortic aneurysms in CTD patients.
Methods: Patient records from the Johns Hopkins Hospital between
August of 2006 and January 2013 were evaluated. Twenty patients were identi-
ﬁed with CTD and underwent branched renovisceral reconstruction for either
typeI, II, orIII thoracoabdominal aortic aneurysms.Follow-updata and imaging
were retrospectively reviewed for technical and postoperative complications.
Results: A total of 20 patients, with an average age of 45 (17-67) years,
were reconstructed with branched Gelweave grafts on left atriofemoral
bypass. Overall mortality was 10% with both deaths occurring in the early
postoperative period (aortic arch rupture at 96 hours and cerebral hemor-
rhage at 120 hours). Of the 18 surviving patients (10 women, 8 men), 64
visceral vessels were reconstructed with a mean follow-up of 23.6 months
(range, 3-47 months). Two renal artery bypasses thrombosed (clinically
silent) in follow-up, yielding a branch patency rate of 97%. Median preoper-
ative creatinine was 0.81 (0.4-1.3) mg/dL and median postoperative creati-
nine was 1.1 (0.4-3.3) mg/dL (P ¼ 0.4). There were no mesenteric
complications or need for hemodialysis. No patients required exploration
for bleeding or secondary procedures to assist in visceral patency, and none
suffered spinal cord injury. On follow-up, there was no additional aneurysmal
degeneration in the replaced aortic segment or renovisceral branches.
Conclusions: Branched aortic surgical grafts eliminate the aorta at risk
for recurrent aneurysms. Branched reconstruction is durable and should be
the method of choice for repair of complex thoracoabdominal aneurysms
in patients with CTD. Furthermore, this technique may benchmark compar-
ison with emerging branched endovascular technology in patients with CTD.
Preoperative Smoking Cessation is Essential in Preventing Early Graft
Failure after Infrainguinal Bypass Surgery
Shalini Selvarajah, Mahmoud B. Malas, James H. Black III, Ying W. Lum,
Brandon W. Propper, Christopher J. Abularrage. Johns Hopkins Hospital,
Baltimore, Md
Objectives: Smoking has been implicated as the single most important
risk factor for the development of peripheral arterial disease (PAD). While
previous studies have found poor long-termoutcomes in smokers undergoing
lower extremity bypass, little data exists as to the effects of persistent tobacco
abuse on the early outcomes of infrainguinal bypass on a national level.
Methods: The American College of Surgeons-National Surgical
Quality Improvement Program database from 2005-2011 was queried for
all patients undergoing infrainguinal bypass. A bivariate analysis was done
to assess pre- and intraoperative risk factors for the primary outcome of
30-day graft failure stratiﬁed by current smoking status. The American
College of Surgeons-National Surgical Quality Improvement Program
considers patients to be nonsmokers if they did not smoke for 12 months
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the independent association of active smoking status with graft failure.
Results: 17,147 infrainguinal bypasses were performed in 7008 (41%)
active smokers and 10,139 (59%) nonsmokers. Active smokers were more
likely to be younger, male, black race, and have a history of chronic obstruc-
tive pulmonary disease (P < .001; all). Nonsmokers were more likely to be
functionally dependent and had signiﬁcantly more comorbidities (ie, hyper-
tension, overweight or obese, diabetes, congestive heart failure, history of
previous cardiac surgery or intervention, and dialysis (P < .001; all). The
presence of critical limb ischemia was similar in both groups (47% of active
smokers vs 46% of nonsmokers; P ¼ .54). More nonsmokers received a tibial
level bypass than active smokers (47% vs 34%; P < .001). There was a trend
toward increased early graft failure in active smokers compared with
nonsmokers (5.5 vs 4.8%; P ¼ .06). When adjusting for other variables,
especially level of bypass, there was an independent association between
active smoking and early graft failure on multivariable analysis (adjusted
OR, 1.22; 95% CI, 1.04-1.42; P ¼ .01).
Conclusions: Although nonsmokers were signiﬁcantly older, had
more comorbidities, and required more distal revascularization, active
smokers still had an increased risk for developing early graft failure. These
results stress the need for smoking cessation prior to lower extremity bypass.
Further research is warranted to determine an optimal period of abstinence
among smokers with PAD to reduce their risk for early graft failure.
Delayed Permanent Access Placement in Incident ESRD Patients: Are
Young Patients Waiting too Long?
Justin R. Wallace, Theodore Yuo, Ellen Dillavou. University of Pittsburgh
Medical Center, Pittsburgh, Pa
Objectives: Over 80% of incident end-stage renal disease (ESRD)
patients initiate hemodialysis (HD) with catheter. Current guidelines lack
temporal recommendations for subsequent permanent access placement
after HD initiation. We compared length of time until ﬁrst permanent access
placement after HD initiation among various patient subgroups.
Methods: The United States Renal Data System dataset for 2006 was
reviewed for patients that initiated HD with a catheter and no maturing
arteriovenous access. We then used current procedural terminology codes
to identify patients who underwent subsequent permanent access surgery;
placement of arteriovenous ﬁstula or arteriovenous graft. Time from HD
initiation to permanent access placement was compared by age, ESRD
etiology, demographic variables and access type. We compared median
times with access placement, and then assessed predictors for access place-
ment within 90 days via multivariable logistic regression.
Results: In 2006, 62% (n ¼ 62,663) of ESRD patients >18 years old
initiated HD with a catheter and no maturing arteriovenous access.
Following initiation of HD, 37% (n ¼ 23,035) of patients had surgery for
permanent access. Timing of ﬁrst access ranged from 1 to 1070 days.
Three-fourths received an AVF, but less than one-half (n ¼ 10,210) were
placed in the ﬁrst 90 days of HD (Table). Age, ESRD etiology, and
access type were all signiﬁcantly associated with time to ﬁrst access. Signif-
icant predictors of access placement within 90 days included non-white race
(OR, 1.08; P ¼ .002), male sex (OR, 1.10; P < .001), age $ 65 (OR, 2.67;
P < .001), prior nephrology care (OR, 1.37; P < .001), and ESRD due to
hypertension or diabetes mellitus (OR, 1.52; P < .001).
Table. Time to ﬁrst access placement, overall and stratiﬁed
Time to ﬁrst access Interquartilen Median rangeAll patients
a23,035 103 53-190
By age category
18-64 9892 139 83-258
65-74 6333 82 43-153
75-84 5554 76 41-135
over 85
a
1256 74 38-128By ESRD etiology
Hypertension 6970 97 50-182
Diabetes 10,934 100 52-188
Nephritis 2284 111 60-196
Congenital 1222 116 62-208
Other 1625 114 66-208By access typeaArteriovenous ﬁstula 17,201 101 54-183
Arteriovenous graft 5834 106 51-213aWithin group median time differences statistically signiﬁcant (P < .001)
using Kruskal Wallis and Wilcoxon rank-sum tests.Conclusions: We found a longer than expected time between HD
initiation and ﬁrst access attempt in patients who initiated HD with catheter
only. Access placement within 90 days was accomplished in less than 17% of
patients and these were most likely older, white, male patients with ESRD
due to DM or HTN. This low percentage of timely access placement,
most evident in younger patients, deserves further investigation.
One Hundred Open Abdominal Aortic Aneurysm Repairs in the
EVAR Era
Omar Haallah. Northshore Long Island Jewish Hospital System, Great
Neck, NY
Objectives: Abdominal aortic aneurysms may be repaired by either
endovascular aneurysm repair (EVAR) or open technique.Most recent studies
showed that EVAR carries a lower mortality rate with a higher intervention
rate. Open surgical repair has a higher perioperative mortality rates and, as
recently shown, has a laparotomy related complications. Still open surgical
repair is considered to be more durable. Our objective is to look at a group
of open surgical repairs in the era of widely accepted endovascular repair.
Methods: Observations of a single surgeon experience for 100 consec-
utive open surgical repairs and253EVARsweremade.Open surgical approach
was chosen for patients unﬁt for endovascular approach or patient preference,
reporting perioperative and postoperative morbidities and mortality at
midterm follow-up and comparing them with the accepted EVAR results.
Results: 100 patients from 100 consecutive procedures of open
surgical repair of aortic aneurysm were observed, of whom 75 were males
and 25 females. Eleven cases were juxtarenal. Eighty-one were approached
transabdominally while the rest were retroperitoneal approach. In seven
cases the inferior mesenteric artery was reimplanted. Complications included
2 postop myocardial infarctions (both underwent coronary artery bypass
graft procedure), 1 postop GI bleeding, 1 postop cerebrovascular accident,
1 renal dysfunction, and 2 postop abdominal wall hernias.
Conclusions: Despite difﬁcult anatomy open surgical repair can be
done safely in the era of EVAR for patient who are either not candidates
for the endovascular approach or who desire the open surgical one.
18F-FDG PET is a Useful Test to Evaluate Inﬂammation Associated
with Human Abdominal Aortic Aneurysm Development
Sean J. Englisha, Frank M. Davisa, Jose A. Diaza, Janet A. Englisha, Tessa
Watta, James R. Stoneb, Morand R. Pierta, Gilbert R. Upchurch Jr.b.
aUniversity of Michigan, Ann Arbor, Mich; bUniversity of Virginia,
Charlottesville, Va
Objectives: A noninvasive test that could document increased inﬂam-
mation in the aortic wall would be useful for identifying markers of impend-
ing (abdominal aortic aneurysm) AAA rupture. This study compared 18F-
ﬂuorodeoxyglucose (18F-FDG) positron emission tomography (PET)
uptake in the infrarenal abdominal aorta of nonaneurysmal patients with
carotid atherosclerosis to that of patients with abdominal aortic aneurysm
(AAA) disease evaluated at a single institution.
Methods: Patients with documented carotid disease by duplex and no
aneurysmal degeneration (control, n ¼ 31 scans) and AAA patients (n ¼ 29
scans) that had undergone whole-body 18F-FDG PET scans were identi-
ﬁed. Regions-of-interest were drawn around the outer wall of the aorta in
each case, from the iliac bifurcation to the crossing of the left renal vein,
and the maximum standard uptake value (SUVmax) was determined along
the infrarenal abdominal aorta (Fig). A Student t-test with a Welch
correction was performed to compare control and AAA patients.
Results: Patient demographics were well matched between the
groups in terms of age, sex, and body mass index, as well as comorbidities
including cancer, hypertension, chronic obstructive pulmonary disease,
congestive heart failure, diabetes mellitus, and hyperlipidemia requiring sta-
tin use. Mean aortic diameters for the control and AAA groups were 2.2 6
0.1 cm and 4.6 6 0.2 cm (P < .0001), respectively. SUVmax values for the
control and AAA groups were 3.1 6 0.1 and 3.8 6 0.3 (P ¼ .03), respec-
tively. No correlation was found between SUVmax and maximum AAA
diameter; however, 70% of SUVmax values were within 5.5 cm of the
maximum AAA diameter along the axis of the AAA. One AAA patient
ruptured 8 days after his 18F-FDG PET scan, with a SUVmax of 4.6 and
a maximum AAA diameter of 4.4 cm.
Conclusions: This study describes one institution’s experience assess-
ing inﬂammation in the AAA wall by 18F-FDG PET, demonstrated by
a 23% greater degree of 18F-FDG uptake by the AAA group. Prospective
comparisons of 18F-FDG uptake by AAAs to other radiotracers that may
demonstrate local inﬂammation, as well as structural changes temporally
demonstrated by computed tomography, are necessary to determine the
predictive value of PET as a tool that may be used to survey AAA patients
in the future and determine AAA rupture risk.
